miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to the cellular modulation of oxidative stress responses. In this role, the miRs can accelerate ovarian tumorigenesis but also endow cancer cells...
Saved in:
Published in | Nature medicine Vol. 17; no. 12; pp. 1627 - 1635 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.12.2011
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to the cellular modulation of oxidative stress responses. In this role, the miRs can accelerate ovarian tumorigenesis but also endow cancer cells with increased sensitivity to ROS-inducing chemotherapy. This two-part effect is reflected on the distinct association of the miRs with patient survival and may be informative for treatment decisions.
Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials. |
---|---|
AbstractList | Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials. [PUBLICATION ABSTRACT] Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials. Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38a and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38a deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials. This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to the cellular modulation of oxidative stress responses. In this role, the miRs can accelerate ovarian tumorigenesis but also endow cancer cells with increased sensitivity to ROS-inducing chemotherapy. This two-part effect is reflected on the distinct association of the miRs with patient survival and may be informative for treatment decisions. Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials. |
Audience | Academic |
Author | Nicolas, André de Feraudy, Yvan Cottu, Paul Mechta-Grigoriou, Fatima Meyniel, Jean-Philippe Cardon, Melissa Sastre-Garau, Xavier Mariani, Odette Mateescu, Bogdan Batista, Luciana Gruosso, Tina |
Author_xml | – sequence: 1 givenname: Bogdan surname: Mateescu fullname: Mateescu, Bogdan organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France – sequence: 2 givenname: Luciana surname: Batista fullname: Batista, Luciana organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France – sequence: 3 givenname: Melissa surname: Cardon fullname: Cardon, Melissa organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France – sequence: 4 givenname: Tina surname: Gruosso fullname: Gruosso, Tina organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France – sequence: 5 givenname: Yvan surname: de Feraudy fullname: de Feraudy, Yvan organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France – sequence: 6 givenname: Odette surname: Mariani fullname: Mariani, Odette organization: Department of Pathology, Institut Curie, Paris, France – sequence: 7 givenname: André surname: Nicolas fullname: Nicolas, André organization: Department of Pathology, Institut Curie, Paris, France – sequence: 8 givenname: Jean-Philippe surname: Meyniel fullname: Meyniel, Jean-Philippe organization: Institut Curie, Functional Genomic Platform – sequence: 9 givenname: Paul surname: Cottu fullname: Cottu, Paul organization: Department of Medical Oncology, Institut Curie – sequence: 10 givenname: Xavier surname: Sastre-Garau fullname: Sastre-Garau, Xavier organization: Department of Pathology, Institut Curie, Paris, France – sequence: 11 givenname: Fatima surname: Mechta-Grigoriou fullname: Mechta-Grigoriou, Fatima email: fatima.mechta-grigoriou@curie.fr organization: Stress and Cancer Laboratory, Institut Curie, Institut National de la Santé et de la Recherche Médicale, U830, Paris, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22101765$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl1rHSEQhqWkNB8t_QdFKPTjYk91d3XXyxCaNBAIpB-U3ojHHTeGXT1RNyT_vi4nbbNwLoqggz7zDvM6h2jPeQcIvaZkRUnVfnLjqmS0fIYOKKt5QRvycy_HpGmLVjC-jw5jvCGEVISJF2i_LCmhDWcH6NdorwpaU6xch-e4JERhpRP2Dvs7FaxyOE2jD7YHB9FGvH7A2rsU_DBY12N_bzuV7B3gmALEiPO28S7CS_TcqCHCq8fzCH0__fzt5EtxcXl2fnJ8UWhOaSq44hQEFYQIQXhnlFHrynBFa1ZrLtakq9qKc9MaDkxD0-TmtGhrpuqGcy6qI_R2q7sJ_naCmOSNn4LLJSXNopQTUbb_qF4NIK0zPgWlRxu1PC6bWjCWPclUsYOaOw9qyJYbm68X_GoHn1cHo9U7Ez4uEmYn4T71aopRnn-9-n_28seSffeEvQY1pOvohynZ_BVL8P0W1MHHGMDITbCjCg_ZLDnPknSjnGcpk28efZ3WI3R_uT_Dk4EPWyDmJ9dDeGr8Uus3ss7Mmg |
CitedBy_id | crossref_primary_10_1002_bies_201200041 crossref_primary_10_1038_s41419_018_1093_9 crossref_primary_10_3389_fphar_2022_924817 crossref_primary_10_3390_cancers11020255 crossref_primary_10_3892_ijmm_2017_3324 crossref_primary_10_3892_ol_2014_1806 crossref_primary_10_1007_s11356_016_6253_9 crossref_primary_10_3389_fmolb_2024_1361601 crossref_primary_10_7314_APJCP_2014_15_20_8595 crossref_primary_10_1101_gr_139758_112 crossref_primary_10_1111_cas_14599 crossref_primary_10_3892_ol_2019_10934 crossref_primary_10_1089_ars_2013_5292 crossref_primary_10_1007_s10571_020_00920_4 crossref_primary_10_1007_s00018_022_04552_3 crossref_primary_10_3892_ol_2018_9444 crossref_primary_10_1016_j_yexcr_2013_04_011 crossref_primary_10_1186_1476_4598_13_221 crossref_primary_10_1007_s12032_023_02128_0 crossref_primary_10_3390_ijms222212530 crossref_primary_10_1002_jcb_25879 crossref_primary_10_1016_j_canlet_2013_01_042 crossref_primary_10_3892_ijo_2018_4497 crossref_primary_10_1016_j_ijheh_2014_01_001 crossref_primary_10_1093_carcin_bgs374 crossref_primary_10_1089_ars_2017_7276 crossref_primary_10_15252_emmm_201505891 crossref_primary_10_1371_journal_pone_0237066 crossref_primary_10_3390_ijms241310798 crossref_primary_10_1038_s41467_024_45595_3 crossref_primary_10_1002_cam4_5388 crossref_primary_10_1152_ajpcell_00137_2012 crossref_primary_10_1186_1476_4598_13_241 crossref_primary_10_1016_j_gene_2018_04_010 crossref_primary_10_1016_j_bbamcr_2013_06_026 crossref_primary_10_3390_medicines5010016 crossref_primary_10_1186_s12943_017_0582_2 crossref_primary_10_3390_v4112485 crossref_primary_10_3389_fonc_2022_999654 crossref_primary_10_1007_s10565_013_9250_5 crossref_primary_10_1089_ars_2023_0253 crossref_primary_10_15252_embj_201797345 crossref_primary_10_1007_s13402_018_00421_z crossref_primary_10_1186_s12967_022_03553_x crossref_primary_10_7314_APJCP_2014_15_17_7015 crossref_primary_10_1111_pbi_14095 crossref_primary_10_18632_oncotarget_18343 crossref_primary_10_3389_fphys_2015_00209 crossref_primary_10_1093_gerona_gly186 crossref_primary_10_1038_s41467_018_03348_z crossref_primary_10_18632_oncotarget_7765 crossref_primary_10_3389_fcell_2021_690542 crossref_primary_10_3389_fonc_2016_00213 crossref_primary_10_1039_D0RA09237A crossref_primary_10_1016_j_humpath_2015_06_013 crossref_primary_10_1016_j_jare_2020_11_006 crossref_primary_10_1016_j_prp_2020_153159 crossref_primary_10_1038_ncomms3977 crossref_primary_10_18632_oncotarget_13917 crossref_primary_10_1007_s00432_022_04101_2 crossref_primary_10_1038_s41598_021_83685_0 crossref_primary_10_1038_ncomms9959 crossref_primary_10_1371_journal_pone_0087782 crossref_primary_10_18632_oncotarget_16878 crossref_primary_10_1038_cddis_2014_573 crossref_primary_10_1586_erm_12_131 crossref_primary_10_3390_ijms19092687 crossref_primary_10_3390_ijms20236094 crossref_primary_10_18632_oncotarget_810 crossref_primary_10_1021_acsomega_3c04856 crossref_primary_10_1038_mt_2014_197 crossref_primary_10_1155_2019_6346529 crossref_primary_10_1038_mt_2014_79 crossref_primary_10_1038_s41388_019_0860_0 crossref_primary_10_1126_scisignal_aao4617 crossref_primary_10_1016_j_redox_2019_101137 crossref_primary_10_1038_s41467_018_07360_1 crossref_primary_10_1155_2013_173783 crossref_primary_10_1016_j_biopha_2020_110729 crossref_primary_10_17116_repro201521330_37 crossref_primary_10_3892_ijmm_2016_2719 crossref_primary_10_18632_oncotarget_20688 crossref_primary_10_1016_j_ijbiomac_2024_133305 crossref_primary_10_1002_gcc_22693 crossref_primary_10_1016_j_aquaculture_2021_736357 crossref_primary_10_4161_cc_26592 crossref_primary_10_1002_cam4_2692 crossref_primary_10_1016_j_redox_2020_101607 crossref_primary_10_3389_fgene_2019_00931 crossref_primary_10_1038_bjc_2016_124 crossref_primary_10_18632_oncotarget_3052 crossref_primary_10_1155_2017_5189138 crossref_primary_10_1242_jcs_133314 crossref_primary_10_1172_JCI63051 crossref_primary_10_1016_j_heliyon_2024_e28442 crossref_primary_10_1155_2019_1041583 crossref_primary_10_1186_s12935_020_01414_5 crossref_primary_10_1002_jgm_3116 crossref_primary_10_3390_ijms222111857 crossref_primary_10_1016_j_biocel_2013_03_001 crossref_primary_10_1155_2013_241780 crossref_primary_10_1158_0008_5472_CAN_14_3242 crossref_primary_10_1016_j_prp_2022_154222 crossref_primary_10_3390_biom12060781 crossref_primary_10_18311_ajprhc_2018_21486 crossref_primary_10_18632_oncotarget_9721 crossref_primary_10_1089_ars_2017_7229 crossref_primary_10_1177_2155179019873849 crossref_primary_10_3892_ol_2019_10736 crossref_primary_10_1002_jso_23572 crossref_primary_10_1007_s12079_020_00548_5 crossref_primary_10_1253_circj_CJ_14_1218 crossref_primary_10_3892_ijo_2012_1658 crossref_primary_10_1002_jcb_29237 crossref_primary_10_1016_j_biopha_2016_09_087 crossref_primary_10_1093_humupd_dmu060 crossref_primary_10_1186_s12943_022_01703_9 crossref_primary_10_1016_j_heliyon_2024_e30328 crossref_primary_10_1002_jcb_24589 crossref_primary_10_1016_j_jgg_2018_03_001 crossref_primary_10_3390_ijms23126702 crossref_primary_10_3389_fphys_2016_00342 crossref_primary_10_14336_AD_2021_0322 crossref_primary_10_1155_2021_3408937 crossref_primary_10_3892_ijo_2013_2189 crossref_primary_10_1172_JCI96313 crossref_primary_10_1124_mol_114_096743 crossref_primary_10_1039_C7MO00119C crossref_primary_10_1016_j_dci_2016_06_004 crossref_primary_10_1016_j_canlet_2018_01_010 crossref_primary_10_3389_fphys_2019_00631 crossref_primary_10_1007_s11010_019_03547_2 crossref_primary_10_1016_j_critrevonc_2023_104220 crossref_primary_10_1016_j_lfs_2021_119263 crossref_primary_10_15430_JCP_2013_18_3_209 crossref_primary_10_1002_jcb_30471 crossref_primary_10_1016_j_cellsig_2023_110688 crossref_primary_10_1371_journal_pone_0174839 crossref_primary_10_1134_S0006297919110026 crossref_primary_10_3390_jcm6030029 crossref_primary_10_1002_emmm_201302732 crossref_primary_10_1186_s13048_019_0575_4 crossref_primary_10_1002_ijc_29568 crossref_primary_10_1038_nrc3265 crossref_primary_10_1016_j_jff_2023_105541 crossref_primary_10_3389_fimmu_2018_00757 crossref_primary_10_3390_ijms130911705 crossref_primary_10_1038_oncsis_2013_9 crossref_primary_10_1007_s12013_013_9801_7 crossref_primary_10_3390_ijms160816833 crossref_primary_10_3892_ijo_2017_4139 crossref_primary_10_3892_or_2015_4451 crossref_primary_10_1016_j_canlet_2019_10_021 crossref_primary_10_3892_mmr_2018_9108 crossref_primary_10_1016_j_dci_2014_03_015 crossref_primary_10_34108_eujhs_543409 crossref_primary_10_2217_epi_2019_0284 crossref_primary_10_1089_ars_2012_4820 crossref_primary_10_1155_2022_2365991 crossref_primary_10_1080_10715762_2017_1339871 crossref_primary_10_4161_cc_11_6_19665 crossref_primary_10_1155_2015_425708 crossref_primary_10_1371_journal_pone_0159686 crossref_primary_10_1016_j_canlet_2014_10_011 crossref_primary_10_18632_oncotarget_7456 crossref_primary_10_3390_ijms140917319 crossref_primary_10_1016_j_freeradbiomed_2013_10_811 crossref_primary_10_3390_ijms25073793 crossref_primary_10_1016_j_yexcr_2017_07_039 crossref_primary_10_1158_1078_0432_CCR_17_2485 crossref_primary_10_1016_j_ydbio_2016_01_041 crossref_primary_10_18632_oncotarget_23074 crossref_primary_10_3390_ijms14034934 crossref_primary_10_1093_nar_gku354 crossref_primary_10_1155_2012_762825 crossref_primary_10_1038_s41388_019_1025_x crossref_primary_10_3390_ijms21197093 crossref_primary_10_1016_j_ccell_2020_01_003 crossref_primary_10_1016_j_scitotenv_2020_140591 crossref_primary_10_1021_es4055516 crossref_primary_10_1038_s41419_022_04976_6 crossref_primary_10_3109_07853890_2015_1043140 crossref_primary_10_1158_1055_9965_EPI_17_0728 crossref_primary_10_47482_acmr_1285642 crossref_primary_10_1080_14712598_2017_1340935 crossref_primary_10_1016_j_juro_2012_11_133 crossref_primary_10_1155_2021_8388258 crossref_primary_10_1038_s41598_021_84421_4 crossref_primary_10_1684_bdc_2012_1542 crossref_primary_10_1038_ncomms9583 crossref_primary_10_1038_aps_2013_35 crossref_primary_10_1186_s13046_020_01680_1 crossref_primary_10_1016_j_ygeno_2018_01_006 crossref_primary_10_1016_j_bios_2022_114900 crossref_primary_10_1155_2018_9207153 crossref_primary_10_1002_chem_201203344 crossref_primary_10_1074_jbc_M112_383273 crossref_primary_10_3389_fgene_2020_00219 crossref_primary_10_1093_carcin_bgac048 crossref_primary_10_1097_PAI_0000000000000169 crossref_primary_10_1126_sciadv_abb0737 crossref_primary_10_1007_s11357_017_0002_y crossref_primary_10_1089_dna_2017_3633 crossref_primary_10_1007_s12094_020_02488_3 crossref_primary_10_1038_s41389_019_0150_2 crossref_primary_10_1038_s10038_020_0819_6 crossref_primary_10_3389_fimmu_2023_1151109 crossref_primary_10_1016_j_redox_2015_05_008 crossref_primary_10_1038_srep41241 crossref_primary_10_1016_j_gene_2019_05_034 crossref_primary_10_1002_jcb_28071 crossref_primary_10_1016_j_semcancer_2013_12_007 crossref_primary_10_1038_s41388_018_0577_5 crossref_primary_10_1158_1078_0432_CCR_20_0103 crossref_primary_10_1186_s13058_015_0652_6 crossref_primary_10_1016_j_biopha_2020_110228 crossref_primary_10_1128_MCB_00099_20 crossref_primary_10_1155_2020_3404059 crossref_primary_10_12677_ACM_2023_1351120 crossref_primary_10_1371_journal_pone_0068990 crossref_primary_10_1177_17590914221101704 crossref_primary_10_3324_haematol_2020_263756 crossref_primary_10_3390_ijms20215322 crossref_primary_10_1242_dev_153817 crossref_primary_10_3892_ijo_2019_4913 crossref_primary_10_1042_CS20140087 crossref_primary_10_1186_1471_2164_15_659 crossref_primary_10_1016_j_dci_2018_05_010 crossref_primary_10_1038_emm_2017_33 crossref_primary_10_3390_ijms21197117 crossref_primary_10_1073_pnas_2015808118 crossref_primary_10_1002_ctm2_1558 crossref_primary_10_1038_s41467_018_03556_7 crossref_primary_10_3390_biology11010023 crossref_primary_10_3390_genes12040552 crossref_primary_10_1530_REP_11_0240 crossref_primary_10_1016_j_mce_2015_07_030 crossref_primary_10_1016_j_ccr_2012_12_020 crossref_primary_10_1016_j_molonc_2015_04_015 crossref_primary_10_3389_fbioe_2022_813070 crossref_primary_10_1186_s43556_020_00004_1 crossref_primary_10_1097_BRS_0000000000004486 crossref_primary_10_1186_s13046_016_0289_z crossref_primary_10_1002_cncr_32079 crossref_primary_10_1007_s00251_012_0677_2 crossref_primary_10_1016_j_yexmp_2018_11_014 crossref_primary_10_1155_2014_249393 crossref_primary_10_1016_j_redox_2018_03_016 crossref_primary_10_1016_j_prp_2019_01_001 crossref_primary_10_1016_j_cmet_2018_09_002 crossref_primary_10_1038_cddis_2016_64 crossref_primary_10_1186_1471_2407_12_627 crossref_primary_10_12938_bmfh_2021_067 crossref_primary_10_1038_nm_2593 crossref_primary_10_1042_CS20130079 crossref_primary_10_3390_ijms18061207 crossref_primary_10_3389_fonc_2021_823603 crossref_primary_10_1371_journal_pone_0193599 crossref_primary_10_1038_s41586_024_07336_w crossref_primary_10_1002_cncr_28002 crossref_primary_10_1016_j_canlet_2013_06_027 crossref_primary_10_1016_j_canlet_2020_06_024 crossref_primary_10_1186_s13046_018_0796_1 crossref_primary_10_1016_j_biopha_2019_109303 crossref_primary_10_1111_are_12624 crossref_primary_10_1182_blood_2012_01_401794 crossref_primary_10_1038_s41598_017_09333_8 crossref_primary_10_1002_iub_2680 crossref_primary_10_3892_ijmm_2016_2553 crossref_primary_10_1111_1365_2435_12477 crossref_primary_10_3390_cancers13143485 crossref_primary_10_1002_mc_22286 crossref_primary_10_1111_apm_12514 crossref_primary_10_1016_j_biopha_2019_108960 crossref_primary_10_1016_j_cellsig_2013_09_006 crossref_primary_10_1089_ars_2019_7918 crossref_primary_10_1111_aogs_12883 crossref_primary_10_1002_ijc_28056 crossref_primary_10_1016_j_heliyon_2023_e22011 crossref_primary_10_1089_ars_2016_6643 crossref_primary_10_1016_j_mrgentox_2013_04_020 crossref_primary_10_1007_s10126_020_09982_3 crossref_primary_10_3892_or_2015_3866 crossref_primary_10_1038_s41388_020_1288_2 crossref_primary_10_1155_2017_2398696 crossref_primary_10_3389_fonc_2020_01533 crossref_primary_10_3390_cancers13153840 crossref_primary_10_7759_cureus_49880 crossref_primary_10_1016_j_mad_2017_08_013 crossref_primary_10_1016_j_ygyno_2014_03_575 crossref_primary_10_18632_genesandcancer_144 crossref_primary_10_1111_liv_12737 crossref_primary_10_1158_1078_0432_CCR_13_3224 crossref_primary_10_3892_ijo_2017_3915 crossref_primary_10_1007_s10456_018_9654_1 crossref_primary_10_1186_s12943_022_01588_8 crossref_primary_10_1002_jcb_30506 crossref_primary_10_1016_j_phrs_2018_09_021 crossref_primary_10_1093_toxsci_kfac066 crossref_primary_10_3389_fonc_2020_01084 crossref_primary_10_1016_j_arr_2012_10_004 crossref_primary_10_1016_j_envint_2019_105055 crossref_primary_10_1158_1078_0432_CCR_18_0784 crossref_primary_10_1016_j_canlet_2013_11_004 crossref_primary_10_3892_mmr_2022_12878 crossref_primary_10_3109_10715762_2013_772604 crossref_primary_10_1016_j_ygyno_2020_11_018 crossref_primary_10_1038_onc_2012_433 crossref_primary_10_1007_s11033_014_3045_5 crossref_primary_10_1002_jcb_29299 crossref_primary_10_1038_onc_2013_597 crossref_primary_10_1186_1471_2164_15_709 crossref_primary_10_1371_journal_pone_0174300 crossref_primary_10_1158_0008_5472_CAN_16_1615 crossref_primary_10_1016_j_fsi_2013_03_353 crossref_primary_10_1155_2018_2754941 crossref_primary_10_1186_s12864_016_3001_y crossref_primary_10_1002_cbf_3694 crossref_primary_10_1002_jcp_29724 crossref_primary_10_1186_1471_2164_15_10 crossref_primary_10_1111_cas_16085 crossref_primary_10_1186_s12933_023_01842_3 crossref_primary_10_1016_j_freeradbiomed_2013_06_009 crossref_primary_10_1155_2022_2751696 crossref_primary_10_3390_cimb44120438 crossref_primary_10_1007_s40495_016_0051_4 crossref_primary_10_1038_s41598_018_25900_z crossref_primary_10_3390_cancers13235878 crossref_primary_10_1038_s41598_021_84953_9 crossref_primary_10_1530_JME_13_0294 crossref_primary_10_3389_fendo_2022_856667 crossref_primary_10_2217_fon_15_251 crossref_primary_10_3389_fgene_2020_00705 crossref_primary_10_1371_journal_pone_0120159 crossref_primary_10_1038_s41420_021_00775_8 crossref_primary_10_1371_journal_pone_0101899 crossref_primary_10_1186_s13073_021_00888_w crossref_primary_10_3892_or_2013_2267 crossref_primary_10_1038_s41598_017_15342_4 crossref_primary_10_1158_1535_7163_MCT_13_0296 crossref_primary_10_3390_ijerph17082766 crossref_primary_10_1038_aps_2017_164 crossref_primary_10_3390_cells9010169 crossref_primary_10_1002_jcb_27326 crossref_primary_10_3390_cancers13112680 crossref_primary_10_1016_j_bbcan_2023_189036 crossref_primary_10_3390_ijms18071560 crossref_primary_10_1016_j_jtherbio_2018_05_008 crossref_primary_10_1016_j_prp_2015_09_014 crossref_primary_10_1038_s41388_021_02067_y crossref_primary_10_1517_14712598_2012_711309 crossref_primary_10_1016_j_trsl_2016_10_001 crossref_primary_10_1261_rna_063941_117 |
Cites_doi | 10.1016/j.cell.2009.07.011 10.1016/j.cell.2009.11.020 10.1677/ERC-10-0148 10.1016/S0140-6736(09)61338-6 10.1158/0008-5472.CAN-06-1894 10.1155/2010/821717 10.1038/nature10167 10.1158/1078-0432.CCR-07-1731 10.1016/S0891-5849(99)00242-7 10.1038/ncb1998 10.1515/BC.2006.167 10.1007/s00018-009-0099-y 10.1158/0008-5472.CAN-05-1162 10.1002/emmm.201000073 10.1002/ijc.25461 10.1101/gad.1820109 10.1084/jem.20110235 10.1074/jbc.M806920200 10.1016/j.cell.2004.08.025 10.1038/sj.cdd.4402222 10.1158/0008-5472.CAN-08-1942 10.4049/jimmunol.0900006 10.1038/nrc2694 10.1016/j.molcel.2010.05.018 10.1186/1755-8794-1-59 10.1016/j.ccr.2007.01.009 10.1038/embor.2008.74 10.1038/ncb2173 10.1371/journal.pone.0005311 10.1016/j.bbadis.2009.12.009 10.1371/journal.pone.0006377 10.1038/ncb1722 10.1016/j.ccr.2006.12.013 10.1158/0008-5472.CAN-07-1058 10.1016/j.ygyno.2009.05.022 10.1186/1471-2407-10-222 10.1158/0008-5472.CAN-07-1936 10.1007/s10555-010-9225-4 10.1158/1535-7163.MCT-09-0965 10.1101/gad.1640608 10.1101/gad.1820209 10.1158/0008-5472.CAN-06-3914 10.1158/1078-0432.CCR-08-0196 10.1016/j.brainres.2010.05.059 10.1016/j.biocel.2010.01.014 10.1016/j.ygyno.2009.04.024 10.1016/S1470-2045(11)70012-2 10.1074/jbc.C800074200 10.1016/j.cmet.2007.12.010 10.1016/j.ygyno.2009.08.009 10.1111/j.1582-4934.2008.00398.x 10.1016/j.biocel.2009.12.017 10.1158/0008-5472.CAN-07-2488 10.1083/jcb.200807026 10.1038/cdd.2011.42 10.1016/j.molcel.2010.08.013 10.1038/ng2033 10.1016/j.cell.2007.09.020 10.1016/j.ygyno.2010.01.010 10.1038/nature10166 |
ContentType | Journal Article |
Copyright | Springer Nature America, Inc. 2011 COPYRIGHT 2011 Nature Publishing Group Copyright Nature Publishing Group Dec 2011 |
Copyright_xml | – notice: Springer Nature America, Inc. 2011 – notice: COPYRIGHT 2011 Nature Publishing Group – notice: Copyright Nature Publishing Group Dec 2011 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QP 7QR 7T5 7TK 7TM 7TO 7U7 7U9 7X7 7XB 88A 88E 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M2P M7N M7P MBDVC P64 PQEST PQQKQ PQUKI Q9U RC3 |
DOI | 10.1038/nm.2512 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Research Library Science Database (ProQuest) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic Genetics Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management Health Research Premium Collection Natural Science Collection Biological Science Collection Chemoreception Abstracts ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals ProQuest SciTech Collection ProQuest Medical Library Animal Behavior Abstracts Immunology Abstracts ProQuest Central (Alumni) |
DatabaseTitleList | Research Library Prep MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1546-170X |
EndPage | 1635 |
ExternalDocumentID | 2643060681 A274955210 10_1038_nm_2512 22101765 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-4 .55 .GJ 0R~ 123 1CY 29M 2FS 36B 39C 3O- 3V. 4.4 53G 5BI 5M7 5RE 5S5 70F 7X7 85S 88A 88E 88I 8AO 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAEEF AARCD AAYOK AAZLF ABAWZ ABCQX ABDBF ABEFU ABJNI ABLJU ABOCM ABUWG ABVXF ACGFO ACGFS ACGOD ACIWK ACMJI ACPRK ADBBV ADFRT AENEX AFBBN AFKRA AFRAH AFSHS AGAYW AGCDD AGEZK AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARMCB ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 DWQXO EAD EAP EBC EBD EBS EE. EJD EMB EMK EMOBN EPL ESX EXGXG F5P FEDTE FQGFK FSGXE FYUFA G8K GNUQQ GUQSH GX1 HCIFZ HMCUK HVGLF HZ~ IAO IEA IH2 IHR IHW INH INR IOF IOV ISR ITC J5H L7B LGEZI LK8 LOTEE M0L M1P M2O M2P M7P MK0 N9A NADUK NNMJJ NXXTH O9- ODYON P2P PQQKQ PROAC PSQYO Q2X RIG RNS RNT RNTTT RVV SHXYY SIXXV SJN SNYQT SV3 TAE TAOOD TBHMF TDRGL TSG TUS UKHRP UQL X7M XJT YHZ ZGI ~8M AAYZH CGR CUY CVF ECM EIF NPM AAYXX ACBWK CITATION AAEXX ABEEJ ADZGE AADEA 7QG 7QL 7QP 7QR 7T5 7TK 7TM 7TO 7U7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N MBDVC P64 PQEST PQUKI Q9U RC3 |
ID | FETCH-LOGICAL-c611t-6a61e919009906dfafab3f6a1454c69b0d38366f8f6e5ce77170c9845a4766693 |
IEDL.DBID | 7X7 |
ISSN | 1078-8956 |
IngestDate | Tue Nov 19 06:42:12 EST 2024 Tue Nov 19 20:35:27 EST 2024 Thu Nov 14 20:43:28 EST 2024 Tue Nov 12 23:25:49 EST 2024 Thu Aug 01 19:28:29 EDT 2024 Thu Aug 01 19:32:37 EDT 2024 Tue Aug 20 21:54:56 EDT 2024 Fri Dec 06 01:18:29 EST 2024 Wed Oct 16 00:48:20 EDT 2024 Fri Oct 11 20:52:16 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c611t-6a61e919009906dfafab3f6a1454c69b0d38366f8f6e5ce77170c9845a4766693 |
PMID | 22101765 |
PQID | 1009160928 |
PQPubID | 33975 |
PageCount | 9 |
ParticipantIDs | proquest_journals_1009160928 gale_infotracmisc_A274955210 gale_infotracgeneralonefile_A274955210 gale_infotracacademiconefile_A274955210 gale_incontextgauss_ISR_A274955210 gale_incontextgauss_IOV_A274955210 gale_healthsolutions_A274955210 crossref_primary_10_1038_nm_2512 pubmed_primary_22101765 springer_journals_10_1038_nm_2512 |
PublicationCentury | 2000 |
PublicationDate | 2011-12-01 |
PublicationDateYYYYMMDD | 2011-12-01 |
PublicationDate_xml | – month: 12 year: 2011 text: 2011-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Nature medicine |
PublicationTitleAbbrev | Nat Med |
PublicationTitleAlternate | Nat Med |
PublicationYear | 2011 |
Publisher | Nature Publishing Group US Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group US – name: Nature Publishing Group |
References | Hui (CR12) 2007; 39 van Jaarsveld, Helleman, Berns, Wiemer (CR44) 2010; 42 Cochrane, Howe, Spoelstra, Richer (CR42) 2010; 2010 Gerald (CR4) 2004; 118 Ramanathan (CR34) 2005; 65 Kim, Choi (CR15) 2010; 1802 Olson (CR48) 2009; 23 Lin (CR18) 2009; 284 Hyun (CR54) 2009; 139 Flynt (CR55) 2009; 185 Wang (CR20) 2010; 1346 Wada (CR13) 2008; 15 Hennessy, Coleman, Markman (CR1) 2009; 374 Laurent (CR6) 2008; 7 Burk (CR24) 2008; 9 Marchini (CR52) 2011; 12 CR2 Allen, Tresini (CR3) 2000; 28 Magenta (CR21) 2011; 18 Mezzanzanica, Bagnoli, De Cecco, Valeri, Canevari (CR43) 2010; 42 Chang (CR32) 2011; 13 Simone (CR19) 2009; 4 Wyman (CR47) 2009; 4 Wagner, Nebreda (CR14) 2009; 9 Nam (CR39) 2008; 14 Yang (CR46) 2008; 68 Eitan (CR51) 2009; 114 Weinberg, Chandel (CR7) 2009; 66 Shimono (CR28) 2009; 138 Hurteau, Carlson, Spivack, Brock (CR22) 2007; 67 Iliopoulos (CR30) 2010; 39 Konstantinopoulos (CR36) 2008; 1 Iorio (CR38) 2007; 67 Pouysségur, Mechta-Grigoriou (CR5) 2006; 387 Hu (CR40) 2009; 114 Tothill (CR45) 2008; 14 Raj (CR59) 2011; 475 Kennedy, Cellurale, Davis (CR11) 2007; 11 Leskelä (CR58) 2011; 18 Schickel, Park, Murmann, Peter (CR31) 2010; 38 Bracken (CR23) 2008; 68 Bendoraite (CR41) 2010; 116 Toullec (CR9) 2010; 2 Karres, Hilgers, Carrera, Treisman, Cohen (CR53) 2007; 131 Liu (CR37) 2010; 9 Korpal, Lee, Hu, Kang (CR26) 2008; 283 Gregory (CR25) 2008; 10 Park, Gaur, Lengyel, Peter (CR27) 2008; 22 Alexandre, Hu, Lu, Pelicano, Huang (CR35) 2007; 67 Marsit, Eddy, Kelsey (CR16) 2006; 66 Gibbons (CR49) 2009; 23 Helleman, Smid, Jansen, van der Burg, Berns (CR57) 2010; 117 Ivan, Harris, Martelli, Kulshreshtha (CR17) 2008; 12 Wellner (CR29) 2009; 11 Wiklund (CR50) 2011; 128 Naidu, Vijayan, Santoso, Kietzmann, Immenschuh (CR56) 2009; 182 Meyniel (CR60) 2010; 10 Kim (CR33) 2011; 208 Pani, Galeotti, Chiarugi (CR8) 2010; 29 Dolado (CR10) 2007; 11 22146456 - Nat Med. 2011 Dec;17(12):1552-4 PA Konstantinopoulos (BFnm2512_CR36) 2008; 1 L Hui (BFnm2512_CR12) 2007; 39 SK Wyman (BFnm2512_CR47) 2009; 4 L Raj (BFnm2512_CR59) 2011; 475 J Alexandre (BFnm2512_CR35) 2007; 67 MV Iorio (BFnm2512_CR38) 2007; 67 DR Cochrane (BFnm2512_CR42) 2010; 2010 GJ Hurteau (BFnm2512_CR22) 2007; 67 Y Lin (BFnm2512_CR18) 2009; 284 A Magenta (BFnm2512_CR21) 2011; 18 A Bendoraite (BFnm2512_CR41) 2010; 116 S Leskelä (BFnm2512_CR58) 2011; 18 P Olson (BFnm2512_CR48) 2009; 23 ED Wiklund (BFnm2512_CR50) 2011; 128 A Toullec (BFnm2512_CR9) 2010; 2 D Mezzanzanica (BFnm2512_CR43) 2010; 42 DL Gibbons (BFnm2512_CR49) 2009; 23 M Ivan (BFnm2512_CR17) 2008; 12 R Eitan (BFnm2512_CR51) 2009; 114 S Marchini (BFnm2512_CR52) 2011; 12 BT Hennessy (BFnm2512_CR1) 2009; 374 S Hyun (BFnm2512_CR54) 2009; 139 EF Wagner (BFnm2512_CR14) 2009; 9 EK Kim (BFnm2512_CR15) 2010; 1802 Y Shimono (BFnm2512_CR28) 2009; 138 MT van Jaarsveld (BFnm2512_CR44) 2010; 42 CJ Chang (BFnm2512_CR32) 2011; 13 BFnm2512_CR2 X Hu (BFnm2512_CR40) 2009; 114 U Burk (BFnm2512_CR24) 2008; 9 G Laurent (BFnm2512_CR6) 2008; 7 H Liu (BFnm2512_CR37) 2010; 9 RG Allen (BFnm2512_CR3) 2000; 28 NJ Kennedy (BFnm2512_CR11) 2007; 11 NL Simone (BFnm2512_CR19) 2009; 4 D Iliopoulos (BFnm2512_CR30) 2010; 39 CJ Marsit (BFnm2512_CR16) 2006; 66 B Ramanathan (BFnm2512_CR34) 2005; 65 PA Gregory (BFnm2512_CR25) 2008; 10 J Pouysségur (BFnm2512_CR5) 2006; 387 JS Karres (BFnm2512_CR53) 2007; 131 I Dolado (BFnm2512_CR10) 2007; 11 D Gerald (BFnm2512_CR4) 2004; 118 Z Wang (BFnm2512_CR20) 2010; 1346 S Naidu (BFnm2512_CR56) 2009; 182 F Weinberg (BFnm2512_CR7) 2009; 66 M Korpal (BFnm2512_CR26) 2008; 283 G Pani (BFnm2512_CR8) 2010; 29 U Wellner (BFnm2512_CR29) 2009; 11 AS Flynt (BFnm2512_CR55) 2009; 185 R Schickel (BFnm2512_CR31) 2010; 38 H Yang (BFnm2512_CR46) 2008; 68 EJ Nam (BFnm2512_CR39) 2008; 14 T Wada (BFnm2512_CR13) 2008; 15 J Helleman (BFnm2512_CR57) 2010; 117 RW Tothill (BFnm2512_CR45) 2008; 14 JP Meyniel (BFnm2512_CR60) 2010; 10 SM Park (BFnm2512_CR27) 2008; 22 T Kim (BFnm2512_CR33) 2011; 208 CP Bracken (BFnm2512_CR23) 2008; 68 |
References_xml | – volume: 138 start-page: 592 year: 2009 end-page: 603 ident: CR28 article-title: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells publication-title: Cell doi: 10.1016/j.cell.2009.07.011 contributor: fullname: Shimono – volume: 139 start-page: 1096 year: 2009 end-page: 1108 ident: CR54 article-title: Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K publication-title: Cell doi: 10.1016/j.cell.2009.11.020 contributor: fullname: Hyun – volume: 18 start-page: 85 year: 2011 end-page: 95 ident: CR58 article-title: The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients publication-title: Endocr. Relat. Cancer doi: 10.1677/ERC-10-0148 contributor: fullname: Leskelä – volume: 374 start-page: 1371 year: 2009 end-page: 1382 ident: CR1 article-title: Ovarian cancer publication-title: Lancet doi: 10.1016/S0140-6736(09)61338-6 contributor: fullname: Markman – volume: 66 start-page: 10843 year: 2006 end-page: 10848 ident: CR16 article-title: MicroRNA responses to cellular stress publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-1894 contributor: fullname: Kelsey – volume: 2010 start-page: 821717 year: 2010 ident: CR42 article-title: Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers publication-title: J. Oncol. doi: 10.1155/2010/821717 contributor: fullname: Richer – volume: 475 start-page: 231 year: 2011 end-page: 234 ident: CR59 article-title: Selective killing of cancer cells by a small molecule targeting the stress response to ROS publication-title: Nature doi: 10.1038/nature10167 contributor: fullname: Raj – volume: 14 start-page: 2690 year: 2008 end-page: 2695 ident: CR39 article-title: MicroRNA expression profiles in serous ovarian carcinoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-07-1731 contributor: fullname: Nam – volume: 28 start-page: 463 year: 2000 end-page: 499 ident: CR3 article-title: Oxidative stress and gene regulation publication-title: Free Radic. Biol. Med. doi: 10.1016/S0891-5849(99)00242-7 contributor: fullname: Tresini – volume: 11 start-page: 1487 year: 2009 end-page: 1495 ident: CR29 article-title: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs publication-title: Nat. Cell Biol. doi: 10.1038/ncb1998 contributor: fullname: Wellner – volume: 387 start-page: 1337 year: 2006 end-page: 1346 ident: CR5 article-title: Redox regulation of the hypoxia-inducible factor publication-title: Biol. Chem. doi: 10.1515/BC.2006.167 contributor: fullname: Mechta-Grigoriou – volume: 66 start-page: 3663 year: 2009 end-page: 3673 ident: CR7 article-title: Reactive oxygen species–dependent signaling regulates cancer publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-009-0099-y contributor: fullname: Chandel – volume: 65 start-page: 8455 year: 2005 end-page: 8460 ident: CR34 article-title: Resistance to paclitaxel is proportional to cellular total antioxidant capacity publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-1162 contributor: fullname: Ramanathan – volume: 2 start-page: 211 year: 2010 end-page: 230 ident: CR9 article-title: Oxidative stress promotes myofibroblast differentiation and tumour spreading publication-title: EMBO Mol. Med. doi: 10.1002/emmm.201000073 contributor: fullname: Toullec – volume: 128 start-page: 1327 year: 2011 end-page: 1334 ident: CR50 article-title: Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer publication-title: Int. J. Cancer doi: 10.1002/ijc.25461 contributor: fullname: Wiklund – volume: 23 start-page: 2152 year: 2009 end-page: 2165 ident: CR48 article-title: MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer publication-title: Genes Dev. doi: 10.1101/gad.1820109 contributor: fullname: Olson – volume: 208 start-page: 875 year: 2011 end-page: 883 ident: CR33 article-title: p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 publication-title: J. Exp. Med. doi: 10.1084/jem.20110235 contributor: fullname: Kim – volume: 284 start-page: 7903 year: 2009 end-page: 7913 ident: CR18 article-title: Involvement of microRNAs in hydrogen peroxide–mediated gene regulation and cellular injury response in vascular smooth muscle cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M806920200 contributor: fullname: Lin – volume: 118 start-page: 781 year: 2004 end-page: 794 ident: CR4 article-title: JunD reduces tumor angiogenesis by protecting cells from oxidative stress publication-title: Cell doi: 10.1016/j.cell.2004.08.025 contributor: fullname: Gerald – volume: 15 start-page: 89 year: 2008 end-page: 93 ident: CR13 article-title: Antagonistic control of cell fates by JNK and p38-MAPK signaling publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4402222 contributor: fullname: Wada – volume: 68 start-page: 7846 year: 2008 end-page: 7854 ident: CR23 article-title: A double-negative feedback loop between ZEB1–SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-1942 contributor: fullname: Bracken – volume: 182 start-page: 7048 year: 2009 end-page: 7057 ident: CR56 article-title: Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2 publication-title: J. Immunol. doi: 10.4049/jimmunol.0900006 contributor: fullname: Immenschuh – volume: 9 start-page: 537 year: 2009 end-page: 549 ident: CR14 article-title: Signal integration by JNK and p38 MAPK pathways in cancer development publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2694 contributor: fullname: Nebreda – volume: 38 start-page: 908 year: 2010 end-page: 915 ident: CR31 article-title: miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1 publication-title: Mol. Cell doi: 10.1016/j.molcel.2010.05.018 contributor: fullname: Peter – volume: 1 start-page: 59 year: 2008 ident: CR36 article-title: Carboplatin-induced gene expression changes are prognostic of survival in epithelial ovarian cancer publication-title: BMC Med. Genomics doi: 10.1186/1755-8794-1-59 contributor: fullname: Konstantinopoulos – volume: 11 start-page: 101 year: 2007 end-page: 103 ident: CR11 article-title: A radical role for p38 MAPK in tumor initiation publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.01.009 contributor: fullname: Davis – volume: 9 start-page: 582 year: 2008 end-page: 589 ident: CR24 article-title: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells publication-title: EMBO Rep. doi: 10.1038/embor.2008.74 contributor: fullname: Burk – volume: 13 start-page: 317 year: 2011 end-page: 323 ident: CR32 article-title: p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs publication-title: Nat. Cell Biol. doi: 10.1038/ncb2173 contributor: fullname: Chang – volume: 4 start-page: e5311 year: 2009 ident: CR47 article-title: Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries publication-title: PLoS ONE doi: 10.1371/journal.pone.0005311 contributor: fullname: Wyman – ident: CR2 – volume: 1802 start-page: 396 year: 2010 end-page: 405 ident: CR15 article-title: Pathological roles of MAPK signaling pathways in human diseases publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2009.12.009 contributor: fullname: Choi – volume: 4 start-page: e6377 year: 2009 ident: CR19 article-title: Ionizing radiation–induced oxidative stress alters miRNA expression publication-title: PLoS ONE doi: 10.1371/journal.pone.0006377 contributor: fullname: Simone – volume: 10 start-page: 593 year: 2008 end-page: 601 ident: CR25 article-title: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1722 contributor: fullname: Gregory – volume: 11 start-page: 191 year: 2007 end-page: 205 ident: CR10 article-title: p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.12.013 contributor: fullname: Dolado – volume: 67 start-page: 7972 year: 2007 end-page: 7976 ident: CR22 article-title: Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-1058 contributor: fullname: Brock – volume: 114 start-page: 457 year: 2009 end-page: 464 ident: CR40 article-title: A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2009.05.022 contributor: fullname: Hu – volume: 10 start-page: 222 year: 2010 ident: CR60 article-title: A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer publication-title: BMC Cancer doi: 10.1186/1471-2407-10-222 contributor: fullname: Meyniel – volume: 67 start-page: 8699 year: 2007 end-page: 8707 ident: CR38 article-title: MicroRNA signatures in human ovarian cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-1936 contributor: fullname: Iorio – volume: 29 start-page: 351 year: 2010 end-page: 378 ident: CR8 article-title: Metastasis: cancer cell′s escape from oxidative stress publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-010-9225-4 contributor: fullname: Chiarugi – volume: 9 start-page: 1080 year: 2010 end-page: 1091 ident: CR37 article-title: mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-09-0965 contributor: fullname: Liu – volume: 22 start-page: 894 year: 2008 end-page: 907 ident: CR27 article-title: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 publication-title: Genes Dev. doi: 10.1101/gad.1640608 contributor: fullname: Peter – volume: 23 start-page: 2140 year: 2009 end-page: 2151 ident: CR49 article-title: Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression publication-title: Genes Dev. doi: 10.1101/gad.1820209 contributor: fullname: Gibbons – volume: 67 start-page: 3512 year: 2007 end-page: 3517 ident: CR35 article-title: Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-3914 contributor: fullname: Huang – volume: 14 start-page: 5198 year: 2008 end-page: 5208 ident: CR45 article-title: Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-08-0196 contributor: fullname: Tothill – volume: 1346 start-page: 14 year: 2010 end-page: 25 ident: CR20 article-title: Profiles of oxidative stress–related microRNA and mRNA expression in auditory cells publication-title: Brain Res. doi: 10.1016/j.brainres.2010.05.059 contributor: fullname: Wang – volume: 42 start-page: 1282 year: 2010 end-page: 1290 ident: CR44 article-title: MicroRNAs in ovarian cancer biology and therapy resistance publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2010.01.014 contributor: fullname: Wiemer – volume: 114 start-page: 253 year: 2009 end-page: 259 ident: CR51 article-title: Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2009.04.024 contributor: fullname: Eitan – volume: 12 start-page: 273 year: 2011 end-page: 285 ident: CR52 article-title: Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(11)70012-2 contributor: fullname: Marchini – volume: 283 start-page: 14910 year: 2008 end-page: 14914 ident: CR26 article-title: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 publication-title: J. Biol. Chem. doi: 10.1074/jbc.C800074200 contributor: fullname: Kang – volume: 7 start-page: 113 year: 2008 end-page: 124 ident: CR6 article-title: Oxidative stress contributes to aging by enhancing pancreatic angiogenesis and insulin signaling publication-title: Cell Metab. doi: 10.1016/j.cmet.2007.12.010 contributor: fullname: Laurent – volume: 116 start-page: 117 year: 2010 end-page: 125 ident: CR41 article-title: Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2009.08.009 contributor: fullname: Bendoraite – volume: 12 start-page: 1426 year: 2008 end-page: 1431 ident: CR17 article-title: Hypoxia response and microRNAs: no longer two separate worlds publication-title: J. Cell Mol. Med. doi: 10.1111/j.1582-4934.2008.00398.x contributor: fullname: Kulshreshtha – volume: 42 start-page: 1262 year: 2010 end-page: 1272 ident: CR43 article-title: Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2009.12.017 contributor: fullname: Canevari – volume: 68 start-page: 425 year: 2008 end-page: 433 ident: CR46 article-title: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-2488 contributor: fullname: Yang – volume: 185 start-page: 115 year: 2009 end-page: 127 ident: CR55 article-title: miR-8 microRNAs regulate the response to osmotic stress in zebrafish embryos publication-title: J. Cell Biol. doi: 10.1083/jcb.200807026 contributor: fullname: Flynt – volume: 18 start-page: 1628 year: 2011 end-page: 1639 ident: CR21 article-title: miR-200c is up-regulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition publication-title: Cell Death Differ. doi: 10.1038/cdd.2011.42 contributor: fullname: Magenta – volume: 39 start-page: 761 year: 2010 end-page: 772 ident: CR30 article-title: Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells publication-title: Mol. Cell doi: 10.1016/j.molcel.2010.08.013 contributor: fullname: Iliopoulos – volume: 39 start-page: 741 year: 2007 end-page: 749 ident: CR12 article-title: p38α suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway publication-title: Nat. Genet. doi: 10.1038/ng2033 contributor: fullname: Hui – volume: 131 start-page: 136 year: 2007 end-page: 145 ident: CR53 article-title: The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in publication-title: Cell doi: 10.1016/j.cell.2007.09.020 contributor: fullname: Cohen – volume: 117 start-page: 170 year: 2010 end-page: 176 ident: CR57 article-title: Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2010.01.010 contributor: fullname: Berns – volume: 475 start-page: 231 year: 2011 ident: BFnm2512_CR59 publication-title: Nature doi: 10.1038/nature10167 contributor: fullname: L Raj – volume: 67 start-page: 3512 year: 2007 ident: BFnm2512_CR35 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-3914 contributor: fullname: J Alexandre – volume: 18 start-page: 85 year: 2011 ident: BFnm2512_CR58 publication-title: Endocr. Relat. Cancer doi: 10.1677/ERC-10-0148 contributor: fullname: S Leskelä – volume: 10 start-page: 593 year: 2008 ident: BFnm2512_CR25 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1722 contributor: fullname: PA Gregory – volume: 65 start-page: 8455 year: 2005 ident: BFnm2512_CR34 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-1162 contributor: fullname: B Ramanathan – ident: BFnm2512_CR2 doi: 10.1038/nature10166 – volume: 185 start-page: 115 year: 2009 ident: BFnm2512_CR55 publication-title: J. Cell Biol. doi: 10.1083/jcb.200807026 contributor: fullname: AS Flynt – volume: 182 start-page: 7048 year: 2009 ident: BFnm2512_CR56 publication-title: J. Immunol. doi: 10.4049/jimmunol.0900006 contributor: fullname: S Naidu – volume: 39 start-page: 741 year: 2007 ident: BFnm2512_CR12 publication-title: Nat. Genet. doi: 10.1038/ng2033 contributor: fullname: L Hui – volume: 374 start-page: 1371 year: 2009 ident: BFnm2512_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(09)61338-6 contributor: fullname: BT Hennessy – volume: 67 start-page: 8699 year: 2007 ident: BFnm2512_CR38 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-1936 contributor: fullname: MV Iorio – volume: 42 start-page: 1262 year: 2010 ident: BFnm2512_CR43 publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2009.12.017 contributor: fullname: D Mezzanzanica – volume: 117 start-page: 170 year: 2010 ident: BFnm2512_CR57 publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2010.01.010 contributor: fullname: J Helleman – volume: 42 start-page: 1282 year: 2010 ident: BFnm2512_CR44 publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2010.01.014 contributor: fullname: MT van Jaarsveld – volume: 14 start-page: 2690 year: 2008 ident: BFnm2512_CR39 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-07-1731 contributor: fullname: EJ Nam – volume: 23 start-page: 2152 year: 2009 ident: BFnm2512_CR48 publication-title: Genes Dev. doi: 10.1101/gad.1820109 contributor: fullname: P Olson – volume: 15 start-page: 89 year: 2008 ident: BFnm2512_CR13 publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4402222 contributor: fullname: T Wada – volume: 2 start-page: 211 year: 2010 ident: BFnm2512_CR9 publication-title: EMBO Mol. Med. doi: 10.1002/emmm.201000073 contributor: fullname: A Toullec – volume: 18 start-page: 1628 year: 2011 ident: BFnm2512_CR21 publication-title: Cell Death Differ. doi: 10.1038/cdd.2011.42 contributor: fullname: A Magenta – volume: 12 start-page: 273 year: 2011 ident: BFnm2512_CR52 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(11)70012-2 contributor: fullname: S Marchini – volume: 28 start-page: 463 year: 2000 ident: BFnm2512_CR3 publication-title: Free Radic. Biol. Med. doi: 10.1016/S0891-5849(99)00242-7 contributor: fullname: RG Allen – volume: 29 start-page: 351 year: 2010 ident: BFnm2512_CR8 publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-010-9225-4 contributor: fullname: G Pani – volume: 38 start-page: 908 year: 2010 ident: BFnm2512_CR31 publication-title: Mol. Cell doi: 10.1016/j.molcel.2010.05.018 contributor: fullname: R Schickel – volume: 131 start-page: 136 year: 2007 ident: BFnm2512_CR53 publication-title: Cell doi: 10.1016/j.cell.2007.09.020 contributor: fullname: JS Karres – volume: 10 start-page: 222 year: 2010 ident: BFnm2512_CR60 publication-title: BMC Cancer doi: 10.1186/1471-2407-10-222 contributor: fullname: JP Meyniel – volume: 66 start-page: 10843 year: 2006 ident: BFnm2512_CR16 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-1894 contributor: fullname: CJ Marsit – volume: 9 start-page: 582 year: 2008 ident: BFnm2512_CR24 publication-title: EMBO Rep. doi: 10.1038/embor.2008.74 contributor: fullname: U Burk – volume: 139 start-page: 1096 year: 2009 ident: BFnm2512_CR54 publication-title: Cell doi: 10.1016/j.cell.2009.11.020 contributor: fullname: S Hyun – volume: 2010 start-page: 821717 year: 2010 ident: BFnm2512_CR42 publication-title: J. Oncol. doi: 10.1155/2010/821717 contributor: fullname: DR Cochrane – volume: 4 start-page: e5311 year: 2009 ident: BFnm2512_CR47 publication-title: PLoS ONE doi: 10.1371/journal.pone.0005311 contributor: fullname: SK Wyman – volume: 7 start-page: 113 year: 2008 ident: BFnm2512_CR6 publication-title: Cell Metab. doi: 10.1016/j.cmet.2007.12.010 contributor: fullname: G Laurent – volume: 23 start-page: 2140 year: 2009 ident: BFnm2512_CR49 publication-title: Genes Dev. doi: 10.1101/gad.1820209 contributor: fullname: DL Gibbons – volume: 9 start-page: 1080 year: 2010 ident: BFnm2512_CR37 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-09-0965 contributor: fullname: H Liu – volume: 14 start-page: 5198 year: 2008 ident: BFnm2512_CR45 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-08-0196 contributor: fullname: RW Tothill – volume: 66 start-page: 3663 year: 2009 ident: BFnm2512_CR7 publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-009-0099-y contributor: fullname: F Weinberg – volume: 1 start-page: 59 year: 2008 ident: BFnm2512_CR36 publication-title: BMC Med. Genomics doi: 10.1186/1755-8794-1-59 contributor: fullname: PA Konstantinopoulos – volume: 13 start-page: 317 year: 2011 ident: BFnm2512_CR32 publication-title: Nat. Cell Biol. doi: 10.1038/ncb2173 contributor: fullname: CJ Chang – volume: 387 start-page: 1337 year: 2006 ident: BFnm2512_CR5 publication-title: Biol. Chem. doi: 10.1515/BC.2006.167 contributor: fullname: J Pouysségur – volume: 11 start-page: 191 year: 2007 ident: BFnm2512_CR10 publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.12.013 contributor: fullname: I Dolado – volume: 1802 start-page: 396 year: 2010 ident: BFnm2512_CR15 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2009.12.009 contributor: fullname: EK Kim – volume: 283 start-page: 14910 year: 2008 ident: BFnm2512_CR26 publication-title: J. Biol. Chem. doi: 10.1074/jbc.C800074200 contributor: fullname: M Korpal – volume: 4 start-page: e6377 year: 2009 ident: BFnm2512_CR19 publication-title: PLoS ONE doi: 10.1371/journal.pone.0006377 contributor: fullname: NL Simone – volume: 1346 start-page: 14 year: 2010 ident: BFnm2512_CR20 publication-title: Brain Res. doi: 10.1016/j.brainres.2010.05.059 contributor: fullname: Z Wang – volume: 114 start-page: 253 year: 2009 ident: BFnm2512_CR51 publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2009.04.024 contributor: fullname: R Eitan – volume: 11 start-page: 101 year: 2007 ident: BFnm2512_CR11 publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.01.009 contributor: fullname: NJ Kennedy – volume: 284 start-page: 7903 year: 2009 ident: BFnm2512_CR18 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M806920200 contributor: fullname: Y Lin – volume: 22 start-page: 894 year: 2008 ident: BFnm2512_CR27 publication-title: Genes Dev. doi: 10.1101/gad.1640608 contributor: fullname: SM Park – volume: 208 start-page: 875 year: 2011 ident: BFnm2512_CR33 publication-title: J. Exp. Med. doi: 10.1084/jem.20110235 contributor: fullname: T Kim – volume: 128 start-page: 1327 year: 2011 ident: BFnm2512_CR50 publication-title: Int. J. Cancer doi: 10.1002/ijc.25461 contributor: fullname: ED Wiklund – volume: 118 start-page: 781 year: 2004 ident: BFnm2512_CR4 publication-title: Cell doi: 10.1016/j.cell.2004.08.025 contributor: fullname: D Gerald – volume: 9 start-page: 537 year: 2009 ident: BFnm2512_CR14 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2694 contributor: fullname: EF Wagner – volume: 68 start-page: 7846 year: 2008 ident: BFnm2512_CR23 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-1942 contributor: fullname: CP Bracken – volume: 138 start-page: 592 year: 2009 ident: BFnm2512_CR28 publication-title: Cell doi: 10.1016/j.cell.2009.07.011 contributor: fullname: Y Shimono – volume: 67 start-page: 7972 year: 2007 ident: BFnm2512_CR22 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-1058 contributor: fullname: GJ Hurteau – volume: 39 start-page: 761 year: 2010 ident: BFnm2512_CR30 publication-title: Mol. Cell doi: 10.1016/j.molcel.2010.08.013 contributor: fullname: D Iliopoulos – volume: 12 start-page: 1426 year: 2008 ident: BFnm2512_CR17 publication-title: J. Cell Mol. Med. doi: 10.1111/j.1582-4934.2008.00398.x contributor: fullname: M Ivan – volume: 11 start-page: 1487 year: 2009 ident: BFnm2512_CR29 publication-title: Nat. Cell Biol. doi: 10.1038/ncb1998 contributor: fullname: U Wellner – volume: 116 start-page: 117 year: 2010 ident: BFnm2512_CR41 publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2009.08.009 contributor: fullname: A Bendoraite – volume: 114 start-page: 457 year: 2009 ident: BFnm2512_CR40 publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2009.05.022 contributor: fullname: X Hu – volume: 68 start-page: 425 year: 2008 ident: BFnm2512_CR46 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-2488 contributor: fullname: H Yang |
SSID | ssj0003059 |
Score | 2.594187 |
Snippet | This report identifies a new contribution of members of the miR-200 family to tumorigenesis. miR-200a and miR-141 specifically regulate p38α, contributing to... Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk... |
SourceID | proquest gale crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1627 |
SubjectTerms | 631/337/384/331 692/420/755 692/699/67/1517/1709 Adult Aged Aged, 80 and over Animals Antioxidants Biomedical and Life Sciences Biomedicine Cancer Research Carcinoma, Ovarian Epithelial Cell Line, Tumor Cell Proliferation Cell Transformation, Neoplastic - genetics Down-Regulation Female Gene expression Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Infectious Diseases Metabolic Diseases Mice Mice, Nude MicroRNA MicroRNAs - genetics MicroRNAs - metabolism Middle Aged Mitogen-Activated Protein Kinase 14 - genetics Mitogen-Activated Protein Kinase 14 - metabolism Molecular Medicine Neoplasms, Glandular and Epithelial - genetics Neoplasms, Glandular and Epithelial - pathology Neurosciences Ovarian cancer Ovarian Neoplasms - genetics Ovarian Neoplasms - pathology Ovarian tumors Oxidative Stress Physiological aspects Ribonucleic acid RNA Stress response Tumors |
Title | miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response |
URI | https://link.springer.com/article/10.1038/nm.2512 https://www.ncbi.nlm.nih.gov/pubmed/22101765 https://www.proquest.com/docview/1009160928 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Nb9MwFH-CTaBdEIyvwBgGITgZ4jRx4xNqYdVA2kCFoWoXy3HsqYcmW5Mi9t_zHLtlmRDilEj5JZJf3offpwFeGRQ-VbCUWmNjmgprqUg0p4ViSunYxFa5eMfRMT88ST_PslkIuDWhrHKtEztFXdbaxchRutGy8Vgk-fvzC-pOjXLZ1XCExk3YZgmacuTn4WzjcDleFr7mMKc5OgK-adaNBH9XLd46y96zRtd18hWjdC1L2hmfyV24E3aNZOR_8z24YapduOXPkbzchdtHIUN-H04X8yllKSOqKom7R_5UROmW1BWpf6JnrCrSrhZuaU7NzRtSXJJQsO5a00n9a15208CJ7yMhS19Gax7AyeTg-4dDGs5PoJoz1lKuODMCLb5LfvHSKquKgeWKpVmquSjiEt1Tzm1uucm0GaJnF2uRp5lKh-jViMFD2KrqyjwGYk2Gos_TokRzVuIuIi8QrpPYsNxkIo-ArOkoz_2YDNmltwe5rBbSkTqC546-0vd3bgRLjtAvFhnuIuIIXnYIN5aicnUvZ2rVNPLTlx__Afo27YHeBJCt26XSKvQa4GLcuKse8nUPeeaHff8NuNcDohTq_uM128igBRr5h2cjeORZaUOdJHHKkGcRvFjz1tUXe6R78u-PP4WdLtLdFdnswVa7XJlnuFVqi_1OHvZhezT-OJ7gdXxw_HX6GyrHESw |
link.rule.ids | 314,780,784,12056,21388,27924,27925,31719,33744,43310,43805,73745,74302 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFD6CTlxeEIxbYDCDEDwZkjTx7Cc00KYO1oLKNk28WI5jT31oMpoUsX_PceyWZUKIt0j5Eikn5-pzA3hlUPhUkWTUGhvTTFhLRaoZLVSilI5NbJU77xhP2Og4-3San4YDtyaUVa50Yqeoy1q7M3KUbrRsLBYpf3_-g7qtUS67GlZoXIcNNzk9H8DGh73J1-laFyM3C191yCnHUMC3zbqh4O-q-Vtn23v26KpWvmSWruRJO_OzfxfuBL-R7PoffQ-umWoTbvhNkhebcHMccuT34ft8NqVJlhBVlcRdI4cqonRL6orUPzE2VhVpl3P3cU7RzRpSXJBQsu6a00n9a1Z288CJ7yQhC19Iax7A8f7e0ccRDRsUqGZJ0lKmWGIE2nyX_mKlVVYVQ8tUkuWZZqKISwxQGbPcMpNrs4OxXawFz3KV7WBcI4YPYVDVlXkMxJochZ9lRYkGrUQ_ghcI12lsEm5ywSMgKzrKcz8oQ3YJ7iGX1Vw6Ukew7egrfYfnWrTkLkbGIkc_Io7gZYdwgykqV_lyppZNIw--nPwH6Nu0B3oTQLZuF0qr0G2AH-MGXvWQr3vIMz_u-2_ArR4Q5VD3b6_YRgY90Mg_XBvBI89Ka-qkqVOHLI_gxYq3Lj_YI92Tf798G26NjsaH8vBg8vkp3O7OvbuSmy0YtIuleYaOU1s8D9LxG6-EEnY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB7BVlRcKiivlEINQnAyjbOJG59Qga5aoEu1UFRxsRzHrvawSdlkEf33jGPv0lQIcYuUL5E8nofH8wJ4YVD4VMFSao2NaSqspSLRnBaKKaVjE1vl7juOx_zwNP1wlp2F_KcmpFUudWKnqMtauztylG60bDwWSb5rQ1rEyfvRm4sf1E2QcpHWME7jJqyhVYyTAay9PRifTFZ6GTlb-AzEnOboFvgSWtcgfLeavXZ2vmebrmvoKybqWsy0M0WjO7ARzpBk32_6Xbhhqk245adKXm7C-nGIl9-D77PphLKUEVWVxD0jtyqidEvqitQ_0U9WFWkXM7c4p_SmDSkuSUhfd4XqpP41Lbve4MRXlZC5T6o19-F0dPD13SEN0xSo5oy1lCvOjED770JhvLTKqmJouWJplmouirhEZ5Vzm1tuMm320M-LtcjTTKV76OOI4QMYVHVlHgGxJkNFwNOiRONW4pkiLxCuk9iw3GQij4As6SgvfNMM2QW7h7msZtKROoIdR1_pqz1XYib30UsWGZ4p4giedwjXpKJy232uFk0jjz5_-w_Ql0kP9CqAbN3OlVah8gAX45pf9ZAve8hz3_r7b8DtHhBlUvdfL9lGBp3QyD8cHMFDz0or6iSJU408i-DZkreuftgj3da_f74D6ygY8tPR-ONjuN1dgXfZN9swaOcL8wTPUG3xNAjHb8lZFqM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=miR-141+and+miR-200a+act+on+ovarian+tumorigenesis+by+controlling+oxidative+stress+response&rft.jtitle=Nature+medicine&rft.au=Mateescu%2C+Bogdan&rft.au=Batista%2C+Luciana&rft.au=Cardon%2C+Melissa&rft.au=Gruosso%2C+Tina&rft.date=2011-12-01&rft.eissn=1546-170X&rft.volume=17&rft.issue=12&rft.spage=1627&rft_id=info:doi/10.1038%2Fnm.2512&rft_id=info%3Apmid%2F22101765&rft.externalDocID=22101765 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-8956&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-8956&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-8956&client=summon |